Empowering Advocacy Through Regulatory Insight: EMA Training for Bleeding Disorders Community
The European Haemophilia Consortium shared a thrilled post on advancing advocacy on X:
”Great to participate in European Medicines Agency training for patients and healthcare professionals! EHC SC Member Marius Tanase joined sessions on scientific advice, regulatory pathways and document review. Valuable insights for Patient Advocacy work!”
Great representation from the bleeding disorders community at the European Medicines Agency (EMA)!
EHC Steering Committee Member Marius Tanase recently took part in a specialized training organized by the EMA for patients and healthcare professionals.
This hands-on experience provided valuable insights that will directly strengthen the efforts, ensuring that patient voices remain central to therapeutic innovation and decision-making processes!
Learn more on coming conferences and trainings in Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia